Reproductive Medicine
Conditions
Interventions
treatment group (FET):Patientsin the treatment group(FET) received oral aspirin 10 mg twice daily (po BID) combined with subcutaneous enoxaparin sodium 40 mg once daily (SC QD), initiated on the day
control group (FET):Patients in the control group(FET) received no intervention.
treatment group (ET):Patientsin the treatment group (ET) received oral aspirin 10 mg twice daily (po BID) combined with subcutaneous enoxaparin sodium 40 mg once daily (SC QD), initiated on the day o
control group (ET):Patients in the control group (ET) received no intervention.
Sponsors
Hefei Maternity and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 43 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged <= 43 years with cryopreserved embryos, scheduled for frozen embryo transfer (FET), demonstrating good compliance, and having provided informed consent with written signature. (2)Infertile patients aged <= 43 years old who are scheduled to undergo IVF-ET (modified long protocol), diagnosed with tubal factor infertility, with good compliance, and who have provided informed consent and signed the agreement.
Exclusion criteria
Exclusion criteria: Exclusion criteria:Autoimmune disorders (e.g., antiphospholipid syndrome, systemic lupus erythematosus, Sjögren’s syndrome, Hashimoto’s thyroiditis, rheumatoid arthritis, primary or secondary renal diseases, Henoch-Schönlein purpura, undifferentiated connective tissue disease); Endometriosis, uterine fibroids, adenomyosis, or uterine anomalies; Chromosomal abnormalities in either partner; Endocrine disorders; Blood group incompatibility; Active infections or other infectious factors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Live birth rate ;linical pregnancy rate ;Implantation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical pregnancy rate ;Multiple pregnancy rate ;Ectopic pregnancy rate ;Miscarriage rate ;Preterm birth rate ; Fetal growth restriction (FGR) incidence ;Hypertensive disorders of pregnancy incidence ; | — |
Countries
China
Contacts
Public ContactTang Zhixia
Hefei Maternity and Child Health Hospital
Outcome results
None listed